Cough syrup deaths: Here are 5 key revelations in Coldrif case

Here are the 5 key revelations in the cough syrup deaths case so far

1) Dr Soni allegedly got a 10% commission for prescribing a cough syrup that has been linked to the casualties. the police told the court.

2) Despite guidelines issued by Directorate General of Health Services, directing that Fixed Dose Combinations (FDCs) not be administered to children below four years of age, Dr Soni continued prescribing such medications and Coldrif syrup, even after being aware that the drug was causing urine retention and kidney failure in children, the police probe report said.

3) The police probe also found that “a medical store adjacent to his private clinic is owned by his relatives, and the stockist of the dangerous syrup in Chhindwara is a family member”.

4) The Sresan Pharmaceuticals, that was closed down by the Tamil Nadu government, located off the Chennai–Bangalore Highway in Sunguvarchatram near Sriperumbudur, has long operated as a modest structure, its closed windows and dusty floors belying its role as a pharmaceutical unit. When The Indian Express visited the facility a week ago, the plant looked more like a petty shop than a medicine factory. Neighbours said women workers in green uniforms used to arrive each morning and leave at dusk. Blue Roquette Liquid Glucose barrels, half-burnt syrup bottles, and charred labels were still visible inside and behind the locked building, remnants of what officials called a hurried clean-up.

5) According to the state’s Drug Control Department, laboratory analysis confirmed that the syrup contained 48.6% diethylene glycol (DEG), a toxic industrial solvent that can cause acute kidney failure and death, and it has since been banned in multiple states. Officials also found that the company had violated over 300 Good Manufacturing Practice (GMP) and Good Laboratory Practice (GLP) standards.